Literature DB >> 17616681

Cholesterol sensitivity of endogenous and myristoylated Akt.

Rosalyn M Adam1, Nishit K Mukhopadhyay, Jayoung Kim, Dolores Di Vizio, Bekir Cinar, Kelly Boucher, Keith R Solomon, Michael R Freeman.   

Abstract

The serine-threonine kinase, Akt, has been linked to cholesterol-sensitive signaling mechanisms, suggesting a possible means whereby cholesterol might affect tumor cell growth and survival. However, it has not been shown whether Akt itself, as distinct from upstream components of the pathway (e.g., membrane phosphoinositides), can be directly responsible for cholesterol-mediated effects. Consistent with this possibility, we identified an Akt1 subpopulation in cholesterol-rich lipid raft fractions prepared from LNCaP human prostate cancer cells. Phosphorylation of this Akt subspecies was ablated with methyl-beta-cyclodextrin, a cholesterol-binding compound, under conditions where nonlipid raft-resident Akt was unaffected. A myristoylated Akt1 (MyrAkt1) fusion protein expressed in LNCaP cells was found to be highly enriched in lipid rafts, indicating that oncogenic Akt is overrepresented in cholesterol-rich membranes compared with wild-type Akt. Notably, lipid raft-resident MyrAkt1 exhibited a markedly distinct substrate preference compared with MyrAkt1 immunoprecipitated from cytosol and nonraft membrane fractions, suggesting a redirection of signal transduction when the protein is present in cholesterol-rich membranes. Expression of MyrAkt1 in LNCaP cells overcame their characteristic dependence on constitutive signaling through the phosphoinositide 3'-kinase pathway. This protective effect was substantially diminished with cyclodextrin treatment. Phosphorylation of Akt substrates in lipid raft fractions, but not in cytosol/nonraft membrane fractions, was ablated with cyclodextrin. In addition, in control (LacZ transfected) cells, lipid raft fractions were relatively enriched in phosphorylated Akt substrates. Collectively, these data show that a subpopulation of Akt is cholesterol sensitive and that the oncogenic effects conferred by myristoylation arise, in part, from the tendency of the membrane-targeted form of the protein to reside in cholesterol-rich membrane microdomains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616681     DOI: 10.1158/0008-5472.CAN-07-0288

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  59 in total

1.  Cluster analysis of insulin action in adipocytes reveals a key role for Akt at the plasma membrane.

Authors:  Yvonne Ng; Georg Ramm; James G Burchfield; Adelle C F Coster; Jacqueline Stöckli; David E James
Journal:  J Biol Chem       Date:  2009-11-06       Impact factor: 5.157

2.  Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.

Authors:  Byron H Lee; Margaret G Taylor; Peggy Robinet; Jonathan D Smith; Jessica Schweitzer; Ephraim Sehayek; Sara M Falzarano; Cristina Magi-Galluzzi; Eric A Klein; Angela H Ting
Journal:  Cancer Res       Date:  2012-12-11       Impact factor: 12.701

3.  G-CSF activation of AKT is not sufficient to prolong neutrophil survival.

Authors:  Liliana R Souza; Erica Silva; Elissa Calloway; Carlos Cabrera; Morgan L McLemore
Journal:  J Leukoc Biol       Date:  2013-04-04       Impact factor: 4.962

4.  Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt.

Authors:  E-K Park; E J Lee; S-H Lee; K H Koo; J Y Sung; E H Hwang; J H Park; C-W Kim; K-C Jeong; B-K Park; Y-N Kim
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 5.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

6.  Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.

Authors:  Dolores Di Vizio; Matteo Morello; Andrew C Dudley; Peter W Schow; Rosalyn M Adam; Samantha Morley; David Mulholland; Mirja Rotinen; Martin H Hager; Luigi Insabato; Marsha A Moses; Francesca Demichelis; Michael P Lisanti; Hong Wu; Michael Klagsbrun; Neil A Bhowmick; Mark A Rubin; Crislyn D'Souza-Schorey; Michael R Freeman
Journal:  Am J Pathol       Date:  2012-09-27       Impact factor: 4.307

7.  Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway.

Authors:  Hyeon Jeong Lee; Jie Li; Renee E Vickman; Junjie Li; Rui Liu; Abigail C Durkes; Bennett D Elzey; Shuhua Yue; Xiaoqi Liu; Timothy L Ratliff; Ji-Xin Cheng
Journal:  Mol Cancer Res       Date:  2018-03-15       Impact factor: 5.852

8.  Two different PDGF beta-receptor cohorts in human pericytes mediate distinct biological endpoints.

Authors:  Christian Sundberg; Tomas Friman; Leah E Hecht; Christine Kuhl; Keith R Solomon
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

9.  Akt signaling dynamics in plasma membrane microdomains visualized by FRET-based reporters.

Authors:  Xinxin Gao; Jin Zhang
Journal:  Commun Integr Biol       Date:  2009

10.  Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains.

Authors:  Xinxin Gao; Jin Zhang
Journal:  Mol Biol Cell       Date:  2008-08-13       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.